glp 1 and semaglutide A Review on Semaglutide: An Oral Glucagon-Like Peptide Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy GLP-1 Weight Loss Options |

Draw Your Diluent: Uncap your mixing syringe

doi: 10.3390/nu16101468 126 SongJLuoXXiongLLiSChenYLiuWet al

EgKI-1 is a member of the Kunitz-type protease inhibitor family, which is important in cancer therapy due to its role in carcinogenesis and cancer progression [44]

doi: 10.3389/fphar.2025.1567863 Received 28 January 2025 Accepted 21 April 2025 Published 01 May 2025 Volume 16 - 2025 Edited by Miguel Oliveira, University of Aveiro, Portugal Reviewed by Yuling Han, Chinese Academy of Sciences (CAS), China Gary Ten Eyck, New York University, United States Satish Polshettiwar, MIT World Peace University, India Updates Copyright 2025 Feng, Qu and Hao

Retatrutide acts on three hormone receptors GLP-1, GIP, and glucagon whereas Ozempic acts on GLP-1 alone